Skip to content Skip to sidebar Skip to footer

Newsletter

News

MTM Critical Metals has changed its name to Metallium, but its just as exciting as it was before!

Effective as of this morning (July 22, 2025), MTM Critical Metals has changed its name to Metallium. This reflects how the company has pivoted from a critical metals explorer to a company commercialising a game-changing metals recycling technology.Metallium's shares have surged from as low as 2.4c in the 2nd half of last year to 81.5c…

ByNick SundichJuly 22, 2025

Lifestyle Communities (ASX: LIC) Shares Plunged 38%: What the Exit Fees Tribunal Ruling Means for Investors

Lifestyle Communities (ASX: LIC) shares experienced a dramatic drop of around 38% after a Victorian Civil and Administrative Tribunal (VCAT) ruling declared certain exit fee clauses in its contracts invalid.This tribunal decision has raised serious concerns about the enforceability of parts of LIC’s revenue model, particularly its reliance on exit fees. The ruling raises concerns…

ByUjjwal MaheshwariJuly 10, 2025

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this magnitude would suggest the FDA knocked back its drug or that it failed a clinical trial.With Botanix having commercialised its treatment, neither was the case, so it'd have to be a pretty bad sales update.…

ByNick SundichJuly 9, 2025

When investors are in a risk off mindset: Here are the 5 moves they usually make and why

Israel’s strikes on Iran, and the subsequent responses, led to the typical "risk off" moves professional investors usually make when faced with uncertainty. But what exactly does "risk off" mean and how relevant is it for retail investors? Should you be risk off too or should you ride out geopolitical uncertainty?Few would've predicted Israel would've…

ByNick SundichJune 18, 2025

June 2025 US Market Outlook: Has the Stock-Market Storm Finally Passed?

The US stock market has seen turbulent times over the past few years. From the COVID-19 pandemic’s market shock to inflation fears, interest rate hikes, and geopolitical instability, investors have been navigating through one storm after another. As we move into June 2025, one key question stands out for investors: Has the storm finally passed?…

ByUjjwal MaheshwariJune 13, 2025

Here Are 3 Important Tax Deductions For Investors You May Be Missing Out On!

As the end of the financial year (EOFY) approaches on 30 June, let's take a look at some of the most important Tax Deductions For Investors in Australia.The EOFY is when many investors assess their finances and maximise available tax benefits. While common deductions, such as mortgage interest on investment properties and depreciation, and brokerage…

ByUjjwal MaheshwariJune 13, 2025

Firstwave Cloud Technology and Amazon: A match made in heaven!

Firstwave Cloud Technology (ASX:FCT) and Amazon have just announced that the pair are teaming up to deploy the former company's product suite onto the latter's AWS marketplace. Shares have gained over 20% this morning off the back of this news. Recap of Firstwave Cloud Technology Firstwave is an ASX-listed technology company. Its historical specialty has been…

ByNick SundichJune 10, 2025

Is Tesla Stock A Good Investment in 2025?

Tesla has captured the imagination of investors and the public alike over the past decade. From its humble beginnings as a startup aiming to revolutionise the automotive industry, Tesla has become one of the most influential companies in the world. As we move deeper into 2025, many investors are asking: Is Tesla stock still a…

ByUjjwal MaheshwariMay 28, 2025

Proteomics’ PromarkerD test for DKD has been launched in Australia, and two more tests will launch later in 2025

2025 has been, and will continue to be, a big year for Proteomics, which has just launched PromarkerD onto the Australian market. Before this year is over, the company anticipates launching another 2 tests - PromarkerEndo and PromarkerEso; and is eyeing off the US market too. Recap of Proteomics (ASX:PIQ) For investors that are new to…

ByNick SundichMay 28, 2025

Why Ventia (ASX: VNT) has more than doubled since its late 2021 listing – second time lucky!

Ventia Services (ASX:VNT) listed on the ASX in November 2021 at $1.5bn and is now capitalised at $4bn. Since listing it has recorded persistent revenue and profit growth. There is very little to complain about from a financial perspective, and it may still be undervalued. However, things aren't completely perfect for it. Overview of Ventia…

ByNick SundichMay 27, 2025

the Kick-ass Multipurpose WordPress Theme

News

MTM Critical Metals has changed its name to Metallium, but its just as exciting as it was before!

Lifestyle Communities (ASX: LIC) Shares Plunged 38%: What the Exit Fees Tribunal Ruling Means for Investors

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

When investors are in a risk off mindset: Here are the 5 moves they usually make and why

June 2025 US Market Outlook: Has the Stock-Market Storm Finally Passed?

Here Are 3 Important Tax Deductions For Investors You May Be Missing Out On!

Firstwave Cloud Technology and Amazon: A match made in heaven!

Is Tesla Stock A Good Investment in 2025?

Proteomics’ PromarkerD test for DKD has been launched in Australia, and two more tests will launch later in 2025

Why Ventia (ASX: VNT) has more than doubled since its late 2021 listing – second time lucky!

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

News

Stocks in Spotlight

Add Your Heading Text Here